Person analyzing chemical experiment by tablet in modern lab

Sector Brief - March 20, 2024

Outsourced Pharma Services & Pharma Tech

Biopharmaceutical companies increasingly rely on technology and service vendors to accelerate R&D and time to market as well as optimize the commercial success of therapies. These companies seek to optimize every portion of the development and commercialization life cycle, creating M&A opportunities for outsourced pharma services and pharma technology. In this Q1 sector brief from our Healthcare & Life Sciences Group and Technology Group, we share insights in the space, including legacy commercialization approaches, solutions that enhance supply chain visibility, drivers of tech implementation, and a focus on real-world evidence and data. 

 

Learn more about M&A trends in this sector.

Download brief

Contacts

Harris-Williams Bio-Crop 0067 1421 PaulHepper

Paul Hepper

Managing Director
Healthcare & Life Sciences

Harris-Williams Bio-Crop 0021 089 DanLinsalata

Dan Linsalata

Managing Director
Technology

Additional Contacts

Harris-Williams Bio-Crop 0040 JulianFeneley 1

Dr. Julian Feneley

Managing Director
Healthcare & Life Sciences

Harris-Williams Bio-Crop 0006 SDoering casual

Stephan Döring

Director
Healthcare & Life Sciences

Harris-Williams Bio-Crop 0003 AndreyDvorkin

Andrey Dvorkin

Director
Healthcare & Life Sciences

bio-crop 0000 0855 RobCrampton

Rob Crampton

Vice President
Healthcare & Life Sciences